JPRN-jRCT1090220305招募中Unknown
Japan Gaucher Research - 002 - JGR-002
Kazuya Tsuboi0 个研究点目标入组 5 人开始时间: 2017年7月28日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 发起方
- 入组人数
- 5
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •1.Patients with a diagnosis of GD based on histological diagnosis, measurements of enzyme activity, and genetic testing.
- •2.Patients receiving treatment with imiglucerase 60 U/kg every two weeks or Velaglucerase alfa 60 U/kg every two weeks.
排除标准
- •1.Patients with osteogenic malignancy or bone metastases were excluded.
研究者
相似试验
招募中
Unknown
Japan Fabry Research - 002Fabry diseaseJPRN-jRCT1090220291Kazuya Tsuboi40
招募中
Unknown
Japan Fabry Research - 001Fabry diseaseJPRN-jRCT1090220293Kazuya Tsuboi20
招募中
3 期
JCOG1502C: Japanese trial -A Global Study To Evaluate The Potential Benefit of Adjuvant Chemotherapy for Small Bowel Adenocarcinomasmall bowel adenocarcinomaJPRN-jRCTs031180008KANEMITSU Yukihide115
已完成
不适用
Survey of Gaucher's Disease in JapaGauchers DiseaseJPRN-UMIN000021839Mebix, Inc Research Operation Depertment1,005
招募中
不适用
J-REGISTER: Japanese REal-world data for treatment of afatinib (GIotrif) in first-line setting and Subsequent Therapies for patients with advanced EGFR mutation-positive lung adenocarcinomaJPRN-UMIN000044071ippon Boehringer Ingelheim Co., Ltd.1,000